pubmed-article:9934480 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9934480 | lifeskim:mentions | umls-concept:C0205208 | lld:lifeskim |
pubmed-article:9934480 | lifeskim:mentions | umls-concept:C0037659 | lld:lifeskim |
pubmed-article:9934480 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
pubmed-article:9934480 | lifeskim:mentions | umls-concept:C0020208 | lld:lifeskim |
pubmed-article:9934480 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
pubmed-article:9934480 | lifeskim:mentions | umls-concept:C0023688 | lld:lifeskim |
pubmed-article:9934480 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
pubmed-article:9934480 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
pubmed-article:9934480 | lifeskim:mentions | umls-concept:C0205549 | lld:lifeskim |
pubmed-article:9934480 | pubmed:issue | 24 | lld:pubmed |
pubmed-article:9934480 | pubmed:dateCreated | 1999-4-5 | lld:pubmed |
pubmed-article:9934480 | pubmed:abstractText | A series of trisubstituted hydantoins has been prepared by a versatile solid phase route employing primary alcohols, amines and amino acids as the monomeric building blocks. Several compounds showed submicromolar affinity in binding assays at recombinant human somatostatin receptors. | lld:pubmed |
pubmed-article:9934480 | pubmed:language | eng | lld:pubmed |
pubmed-article:9934480 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9934480 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9934480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9934480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9934480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9934480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9934480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9934480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9934480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9934480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9934480 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9934480 | pubmed:month | Dec | lld:pubmed |
pubmed-article:9934480 | pubmed:issn | 0960-894X | lld:pubmed |
pubmed-article:9934480 | pubmed:author | pubmed-author:MurrayP JPJ | lld:pubmed |
pubmed-article:9934480 | pubmed:author | pubmed-author:BarkerM DMD | lld:pubmed |
pubmed-article:9934480 | pubmed:author | pubmed-author:JarvieE MEM | lld:pubmed |
pubmed-article:9934480 | pubmed:author | pubmed-author:Scici?skiJ... | lld:pubmed |
pubmed-article:9934480 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9934480 | pubmed:day | 15 | lld:pubmed |
pubmed-article:9934480 | pubmed:volume | 8 | lld:pubmed |
pubmed-article:9934480 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9934480 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9934480 | pubmed:pagination | 3609-14 | lld:pubmed |
pubmed-article:9934480 | pubmed:dateRevised | 2005-11-17 | lld:pubmed |
pubmed-article:9934480 | pubmed:meshHeading | pubmed-meshheading:9934480-... | lld:pubmed |
pubmed-article:9934480 | pubmed:meshHeading | pubmed-meshheading:9934480-... | lld:pubmed |
pubmed-article:9934480 | pubmed:meshHeading | pubmed-meshheading:9934480-... | lld:pubmed |
pubmed-article:9934480 | pubmed:meshHeading | pubmed-meshheading:9934480-... | lld:pubmed |
pubmed-article:9934480 | pubmed:meshHeading | pubmed-meshheading:9934480-... | lld:pubmed |
pubmed-article:9934480 | pubmed:meshHeading | pubmed-meshheading:9934480-... | lld:pubmed |
pubmed-article:9934480 | pubmed:meshHeading | pubmed-meshheading:9934480-... | lld:pubmed |
pubmed-article:9934480 | pubmed:meshHeading | pubmed-meshheading:9934480-... | lld:pubmed |
pubmed-article:9934480 | pubmed:meshHeading | pubmed-meshheading:9934480-... | lld:pubmed |
pubmed-article:9934480 | pubmed:meshHeading | pubmed-meshheading:9934480-... | lld:pubmed |
pubmed-article:9934480 | pubmed:meshHeading | pubmed-meshheading:9934480-... | lld:pubmed |
pubmed-article:9934480 | pubmed:year | 1998 | lld:pubmed |
pubmed-article:9934480 | pubmed:articleTitle | The solid phase synthesis of a series of tri-substituted hydantoin ligands for the somatostatin SST5 receptor. | lld:pubmed |
pubmed-article:9934480 | pubmed:affiliation | Glaxo Wellcome Cambridge Chemistry Laboratory, University Chemical Laboratories, UK. jjs0985@glaxowellcome.co.uk | lld:pubmed |
pubmed-article:9934480 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:9934480 | lld:chembl |